Federico Mercolini

Bologna, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Omitting Bone Marrow Sampling in FDG-Avid Rhabdomyosarcoma With 2-[18F]FDG PET-Negative Marrow: Results From an International Retrospective Study.

Omitting Bone Marrow Sampling in FDG-Avid Rhabdomyosarcoma With 2-[18F]FDG PET-Negative Marrow: Results From an International Retrospective Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 24, 2026

GD2-targeted immunotherapy in pediatric bone sarcomas: a systematic review of emerging strategies and combination approaches.

GD2-targeted immunotherapy in pediatric bone sarcomas: a systematic review of emerging strategies and combination approaches.

Journal: Frontiers in immunology

Published: May 29, 2026

Phase II Study of Allogeneic Hematopoietic Stem Cell Transplantation for Children and Young Adults with Ewing Sarcoma.

Phase II Study of Allogeneic Hematopoietic Stem Cell Transplantation for Children and Young Adults with Ewing Sarcoma.

Journal: Transplantation and cellular therapy

Published: May 26, 2026

Thrombopoietin Receptor Agonists for Treating Poor Graft Function and Thrombocytopenia Post-Autologous Stem Cell Transplantation in Children.

Thrombopoietin Receptor Agonists for Treating Poor Graft Function and Thrombocytopenia Post-Autologous Stem Cell Transplantation in Children.

Journal: European journal of haematology

Published: January 05, 2026

Mapping Genomic Heterogeneity in Pediatric and Adolescent-Young Adult Sarcomas: Insights from the Italian SAR-GEN2016 and SAR-GEN_ITA Prospective Multicenter Trials.

Mapping Genomic Heterogeneity in Pediatric and Adolescent-Young Adult Sarcomas: Insights from the Italian SAR-GEN2016 and SAR-GEN_ITA Prospective Multicenter Trials.

Journal: Cancer research communications

Published: November 06, 2025

Risk Stratification for Cardiotoxicity in Childhood Cancer Survivors: State-of-the-Art Review and a Novel Two-Step Approach.

Risk Stratification for Cardiotoxicity in Childhood Cancer Survivors: State-of-the-Art Review and a Novel Two-Step Approach.

Journal: Cancers

Published: October 02, 2025

Diagnostic Delay and Survival in Pediatric Rhabdomyosarcoma: Is Time a Critical Factor?

Diagnostic Delay and Survival in Pediatric Rhabdomyosarcoma: Is Time a Critical Factor?

Journal: Journal of pediatric hematology/oncology

Published: April 18, 2025

Single site metastatic rhabdomyosarcoma: An INternational Soft Tissue saRcoma ConsorTium (INSTRuCT) pooled analysis.

Single site metastatic rhabdomyosarcoma: An INternational Soft Tissue saRcoma ConsorTium (INSTRuCT) pooled analysis.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 10, 2025

The epidemiological landscape of bloodstream infections in children undergoing chemotherapy or haematopoietic cell transplantation: A retrospective study by Infectious Diseases Working Group of Italian Association of Pediatric Hematology and Oncology (AIEOP).

The epidemiological landscape of bloodstream infections in children undergoing chemotherapy or haematopoietic cell transplantation: A retrospective study by Infectious Diseases Working Group of Italian Association of Pediatric Hematology and Oncology (AIEOP).

Journal: British journal of haematology

Published: February 12, 2025

Lymph Node Staging and Treatment in Pediatric Patients With Soft Tissue Sarcomas: A Consensus Opinion From the Children's Oncology Group, European paediatric Soft Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe.

Lymph Node Staging and Treatment in Pediatric Patients With Soft Tissue Sarcomas: A Consensus Opinion From the Children's Oncology Group, European paediatric Soft Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe.

Journal: Pediatric blood & cancer

Published: July 11, 2024

Managing acute COVID-19 in immunocompromised pediatric patients.

Managing acute COVID-19 in immunocompromised pediatric patients.

Journal: Expert review of clinical immunology

Published: December 15, 2023

Inflammatory Myofibroblastic Tumor With ROS1 Gene Fusions in Children and Young Adolescents.

Inflammatory Myofibroblastic Tumor With ROS1 Gene Fusions in Children and Young Adolescents.

Journal: JCO precision oncology

Published: October 19, 2023

Showing 1-12 of 34

Last Updated: 09/26/2026